News
Iambic files IPO after signing up AbbVie as new partner
In the space of a day, Iambic has filed an IPO, released the latest version of its AI platform, and signed a multi-year alliance with AbbVie.
News
ADARx, Trex, and Retension take aim at IPOs
The appetite among biotechs for IPOs shows no signs of being satisfied, with three more – ADARx, TRex, and Retension – making their intentions known.
News
Beacon's XLRP gene therapy set for filing after phase 3 win
Beacon is preparing to file for approval of its gene therapy for X-linked retinitis pigmentosa, after reporting encouraging phase 3 data.
News
Under pressure, Novo lays out blockbuster launch plans
Novo has revealed a plan to launch five or more blockbusters between now and 2030 that it hopes will grow annual revenues by around $23bn.
R&D
Alzheimer's research is moving toward more selective targets
As we mark World Alzheimer’s Day, it is worth reflecting on the progress made in recent years.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
